Nuformix (LON:NFX) Shares Up 11.8% – Here’s Why

Nuformix plc (LON:NFX) traded up 11.8% during mid-day trading on Tuesday . The stock traded as high as GBX 0.10 ($0.00) and last traded at GBX 0.09 ($0.00). 56,631,465 shares were traded during mid-day trading, a decline of 22% from the average session volume of 72,646,188 shares. The stock had previously closed at GBX 0.08 ($0.00).

Nuformix Stock Performance

The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17. The company’s 50-day simple moving average is GBX 0.06 and its 200-day simple moving average is GBX 0.09. The stock has a market capitalization of £761,958.30, a price-to-earnings ratio of -1.63 and a beta of 1.22.

Nuformix (LON:NFX) last announced its quarterly earnings results on Wednesday, January 29th. The company reported GBX (0.46) (($0.01)) earnings per share (EPS) for the quarter.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.